Gotto A M, Brown W V, Levy R I, Birnbaumer M E, Fredrickson D S
J Clin Invest. 1972 Jun;51(6):1486-94. doi: 10.1172/JCI106945.
The major apoprotein(s) from human plasma low density lipoproteins was isolated and compared with a major protein fraction (fraction I) from very low density lipoproteins (VLDL). Fraction I had been previously found to comprise approximately 40% of the total protein of VLDL. Fraction I from VLDL and apoLDL from normal subjects were indistinguishable in amino acid compositions and circular dichroic spectra. They yielded indistinguishable displacement curves of LDL-(125)I by radioimmunoassay and formed immunoprecipitin lines of complete identity. Fraction I from VLDL of normal subjects was compared with the fraction isolated from patients with familial types II, III, IV, and V hyperlipoproteinemia. There were no detectable differences between any of these fractions in amino acid compositions, circular dichroic spectra, and immunochemical properties. It was, therefore, concluded that short of peptide mapping or determination of amino acid sequence, fraction I from VLDL of each subject with familial hyperlipoproteinemia appears to be identical with fraction I and apoLDL from normal individuals.A new convenient method of preparation of soluble apoLDL, modified from a procedure previously described from this laboratory, is presented.
从人血浆低密度脂蛋白中分离出主要载脂蛋白,并与极低密度脂蛋白(VLDL)中的一种主要蛋白质组分(组分I)进行比较。先前已发现组分I约占VLDL总蛋白的40%。正常受试者的VLDL中的组分I和载脂蛋白LDL在氨基酸组成和圆二色光谱方面无法区分。通过放射免疫测定,它们产生了无法区分的LDL-(125)I置换曲线,并形成了完全相同的免疫沉淀线。将正常受试者的VLDL中的组分I与从家族性II型、III型、IV型和V型高脂血症患者中分离出的组分进行比较。在这些组分的氨基酸组成、圆二色光谱和免疫化学性质方面未检测到差异。因此得出结论,除了肽图谱分析或氨基酸序列测定外,每个家族性高脂血症受试者的VLDL中的组分I似乎与正常个体的组分I和载脂蛋白LDL相同。本文介绍了一种新的简便的可溶性载脂蛋白LDL制备方法,该方法是对本实验室先前描述的方法进行改进而来的。